/ Exosens is proud to announce the expansion of Photonis’ Ultimate Detection Scientific Imaging product portfolio with the introduction of the 25 mm Image Intensifier solution. This latest technology will be showcased at SPIE Photonics West from January 30 to
/ With cancer projected to escalate to 29 million cases by 2040[1], Novigenix, a pioneer in AI healthcare solutions, is rewriting the rules of cancer care. Their newest innovation, LITOSeek™, is primed to reshape drug development, offering a transformative leap
/ Silent Partner Software, a leader in providing software solutions for nonprofits, today announced the launch of a new brand identity, vision, and name: Societ.
With a motive to uncover new layers of innovation in the iGaming industry and showcase its comprehensive iGaming offerings including but not limited to iGaming platform, sports betting software, provably fair casino games, online casino software, sweepstakes casino, slot development,
/ International Water-Guard Industries, Inc. (IWG) and Jet2.com have entered into an agreement to install IWG’s patented “Pre-Select” Intelligent Water Quantity System on 52 B737-800 NG aircraft, making Jet2.com the first airline in Europe to use the product.
UVify’s IFO Earns Coveted ‘Best LED Light Show Drone’ Award at LDI 2023
/ Mahmoud Farshchian, 93, the renowned Iranian artist, continues to captivate art enthusiasts with his exceptional talent and artistic vision. FarshchianART — a foundation created by the Farschian family and dedicated to collecting, exhibiting, preserving, and interpreting the art and
/ Embark on a digital artistic journey with an award-winning painting software; Rebelle 7 by Escape Motions is now released to the public. Dive into a world of living canvas, where oils, acrylics, watercolors, and diverse tools blend seamlessly, capturing
/ Moolec Science SA (NASDAQ:MLEC), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the first quarter of Fiscal Year 2024 ended September 30, 2023.
Sport-Inspired Brand Collaborates with Verite for Exclusive Sport & Culinary Experience
/ Cognomovement, a pioneer in cognitive science-based wellness solutions, today announced the launch of CognoCravings, an innovative program designed to combat stress-induced cravings and improve overall health during the holiday season. This revolutionary approach is rooted in advanced cognitive science
Innovating a new era in endoscopic obesity treatment with Nitinotes’ EndoZip™ System, a revolutionary, fully automated suturing device.
Exosens signs a partnership with Scientific Imaging, Inc. to distribute its two main products brands: Photonis and Xenics.
The product’s easy-to-use dashboards empower companies to accurately benchmark and forecast performance, calculate robust customer health scores, and more.
/ American Wave Machines, Inc. (AWM) announced that AWM patents challenged by WhiteWater West Industries, Ltd. (WW), a waterpark attraction supplier and promoter of Endless Surf, have been reviewed and validated by the United States Patent and Trademark Office (USPTO).
Members of the BGEB leadership team will travel to Dubai to join world leaders, politicians, experts, and private sector leaders for a discussion of the climate crisis, and solutions at hand, on a global level.
/ Photonis, a subsidiary of Exosens, a market-leading global provider of electro-optic solutions used in the detection and amplification of photons, ions, electrons, and neutrons, is thrilled to announce a pivotal milestone in its journey toward advancing nuclear reactor technology.
/ Social Links, a leading open-source intelligence (OSINT) software provider, introduces SL Crimewall, a cutting-edge OSINT investigation platform designed to simplify the entire intelligence cycle, from data extraction, through visualization and processing, to the final report.
A significant milestone in the quest for enhancing the resilience and security of critical financial infrastructure.
A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
